What should I know about clinical trials
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Clinical Trials: A Comprehensive Guide
Clinical trials are research studies that test new treatments, drugs, or approaches to cancer care. Here's what you should know:
What [facility removed]al Trials?
Clinical trials evaluate whether new treatments are safe and effective before they become standard care. They test innovations like new drugs, drug combinations, surgical techniques, radiation methods, or prevention strategies.
According to the National Cancer Institute (NCI), clinical trials happen in phases:
- Phase I: Tests safety and dosage (20-80 participants)
- Phase II: Evaluates effectiveness and side effects (100-300 participants)
- Phase III: Compares new treatment to standard care (hundreds to thousands of participants)
- Phase IV: Monitors long-term effects after FDA approval
Key Benefits to Consider
The American Cancer Society highlights these potential advantages:
- Access to promising new treatments before they're widely available
- Close monitoring by a specialized medical team
- Contributing to cancer research that helps future patients
- Receiving cutting-edge care at no cost (investigational treatment is typically free)
Important Considerations
ASCO (American Society of Clinical Oncology) Guidelines emphasize understanding:
- Eligibility criteria: Specific requirements based on cancer type, stage, and prior treatments
- Informed consent: You'll receive detailed information about risks, benefits, and alternatives
- Randomization: Some trials randomly assign treatments; you may receive standard care instead of the experimental treatment
- Side effects: New treatments may have unknown or unexpected side effects
- Time commitment: More frequent visits and monitoring than standard care
Protections in Place
All clinical trials must be:
- Approved by an Institutional Review Board (IRB) that protects participant rights
- Registered with the FDA and monitored for safety
- Conducted with your voluntary informed consent - you can leave at any time
Finding Trials
The NCI recommends these resources:
- ClinicalTrials.gov: Comprehensive federal database
- NCI's Cancer Information Service: 1-800-4-CANCER
- Your oncologist's recommendations
- Major cancer centers often have trial coordinators
Questions to Ask Your Team
- What is the purpose of this trial?
- What are the potential risks and benefits compared to standard treatment?
- What will my participation involve (visits, tests, duration)?
- Who will oversee my care?
- What happens if the treatment doesn't work or I experience side effects?
- Will I have any costs?
Important to Remember
Clinical trials are completely voluntary. Choosing not to participate won't affect your standard care. Many patients find trials offer hope and access to innovation, while others prefer established treatments.
Your healthcare team is your best resource for discussing whether a specific trial matches your situation, values, and treatment goals.
Would you like help finding trials for a specific cancer type, or do you have questions about a particular trial you're considering?
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Related Services
Services that may help with clinical trials for cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ